Synthesis and evaluation of [F-18] labeled benzamides: High affinity sigma receptor ligands for PET imaging

被引:39
作者
Dence, CS
John, CS
Bowen, WD
Welch, MJ
机构
[1] WASHINGTON UNIV,SCH MED,MALLINCKRODT INST RADIOL,ST LOUIS,MO 63110
[2] GEORGE WASHINGTON UNIV,MED CTR,WASHINGTON,DC 20037
[3] NIDDKD,NIH,BETHESDA,MD 20892
来源
NUCLEAR MEDICINE AND BIOLOGY | 1997年 / 24卷 / 04期
关键词
fluorine-18; positron emission tomography; benzamides; sigma receptors; MALIGNANT-MELANOMA; AUTORADIOGRAPHIC LOCALIZATION; ANTIPSYCHOTIC-DRUGS; BINDING-SITES; GUINEA-PIG; BRAIN; TUMORS; CELLS;
D O I
10.1016/S0969-8051(97)00001-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We have synthesized and characterized four new fluorinated halobenzamides as sigma receptor ligands for use with positron emission tomography (PET). All the compounds were found to have high sigma-1 affinities (K-i = 0.38-0.98 nM), and the 4-fluoro substituted benzamides were found to he more potent sigma-2 ligands (K-i = 3.77-4.02 nM) than their corresponding 2-fluoro analogs (K-i = 20.3-22.8 nM). The [F-18] radiochemical syntheses of two of the analogs gave overall yields between 3-10% (EOS), radiochemical purities >99%, and specific activities between 800-1200 Ci/mmol (29.6-44.4 TBq/mmol). Rat biodistribution and blocking experiments were performed with 2-[F-18]( N-fluorobenzylpiperidin-4yl)-4-iodobenzamide, the analog with the best K-i value for sigma-1 sites (0.38 nM). Results of these experiments demonstrate specific uptake of the compound in tissues believed to contain sigma receptors, such as lungs, kidneys, heart, brain, and spleen and indicate its potential as a candidate for use in PET imaging of tissues containing these receptors. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:333 / 340
页数:8
相关论文
共 34 条
  • [1] BEM WT, 1991, CANCER RES, V51, P6558
  • [2] Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117
  • [3] Dence C. S., 1995, Journal of Labelled Compounds and Radiopharmaceuticals, V37, P115
  • [4] Dence C. S., 1995, Journal of Labelled Compounds and Radiopharmaceuticals, V37, P263
  • [5] Gong Jialing L., 1993, Journal of Labelled Compounds and Radiopharmaceuticals, V32, P314
  • [6] GUNDLACH AL, 1986, J NEUROSCI, V6, P1757
  • [7] A SIGMA-LIKE BINDING-SITE IN RAT PHEOCHROMOCYTOMA (PC12) CELLS - DECREASED AFFINITY FOR (+)-BENZOMORPHANS AND LOWER MOLECULAR-WEIGHT SUGGEST A DIFFERENT SIGMA RECEPTOR FORM FROM THAT OF GUINEA-PIG BRAIN
    HELLEWELL, SB
    BOWEN, WD
    [J]. BRAIN RESEARCH, 1990, 527 (02) : 244 - 253
  • [8] RAT-LIVER AND KIDNEY CONTAIN HIGH-DENSITIES OF SIGMA(1) AND SIGMA(2) RECEPTORS - CHARACTERIZATION BY LIGAND-BINDING AND PHOTOAFFINITY-LABELING
    HELLEWELL, SB
    BRUCE, A
    FEINSTEIN, G
    ORRINGER, J
    WILLIAMS, W
    BOWEN, WD
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 268 (01): : 9 - 18
  • [9] John C. S., 1994, Journal of Labelled Compounds and Radiopharmaceuticals, V35, P242
  • [10] JOHN CS, 1993, J NUCL MED, V34, P2169